Expression and clinical significance of TTF-1 and p63 in NSCLC

Chinese Journal of Lung Cancer

Volumn 12, Issue 9, 2009, Pages 995-999

  Zhang, Peng ^a   Han, Yiping ^a   Huang, Ling ^a   Li, Qiang ^a   Ma, Dalie ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Immunohistochemistry; NSCLC; p63; TTF 1

Indexed keywords

PROTEIN P63; THYROID TRANSCRIPTION FACTOR 1;

ADULT; ARTICLE; CANCER STAGING; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; LUNG DISEASE; LUNG NON SMALL CELL CANCER; MALE; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

EID: 70350449429     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2009.09.010     Document Type: Article

References (12)

1. Kargi A, Gurel D, Tuna B. The diagnostic value of TTF-1, CK5/6, and p63 immunostaining in classification of lung carcinomas. Appl Immunohisto chem Mol Morphol, 2007, 15(4): 415-420.
2. Tan D, Li Q, Deeb G, et al. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Hum Pathol, 2003, 34(6): 597-604. (Pubitemid 36750372)
3. Stenhouse G, Fyfe N, King G, et al. Thyroid transcription factor 1 in pulmonary adenocarcinoma. J Clin Pathol, 2004, 57(4): 383-387. (Pubitemid 38446256)
4. Uramoto H, Sugio K, Oyama T, et al. Expression of the P53 family in lung cancer. Anticancer Res, 2006, 26(3A): 1785-1790. (Pubitemid 43989432)
5. Au NH, Gown AM, Cheang M, et al. p63 expression in lung carcinoma: a tissue microarray study of 408 cases. Appl Immunohistochem Mol Morphol, 2004, 12(3): 240-247.
6. Chang YL, Lee YC, Liao WY, et al. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Lung Cancer, 2004, 44(2): 149-157.
7. Berghmans T, Paesmans M, Mascaux C, et al. Thyroid transcription factor 1-a new prognostic factor in lung cancer: a meta-analysis. Ann Oncol, 2006, 17(11): 1673-1676. (Pubitemid 44680888)
8. Yu YW, Garber ME, Schlüns K, et al. Evaluation of p63 expression in lung cancer by use of complementary DNA and tissue microarray. Zhonghua Bing Li Xue Za Zhi, 2004, 33(4): 324-327.
9. Barbieri CE, Tang LJ, Brown &, et al. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Cancer Res, 2006, 66(15): 7589-7597.
10. Massion PP, Taflan PM, Jamshedur Rahman SM, et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res, 2003, 63(21): 7113-7121. (Pubitemid 37413448)
11. Wu M, Wang B, Gil J, et al. p63 and TTF-1 immunostaining, a useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol, 2003, 119(5): 696-702. (Pubitemid 37051496)
12. Kalhor N, Zander DS, Liu J. TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material. Mod Pathol, 2006, 19(8): 1117-1123 (Pubitemid 44106727)